3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
432
Neoplasms
371
Prostatic Neoplasms
205
Lung Neoplasms
191
Colorectal Neoplasms
153
Motor Activity
94
Uterine Cervical Neoplasms
81
Pancreatic Neoplasms
78
Head and Neck Neoplasms
75
Carcinoma, Non-Small-Cell Lung
72
Brain Neoplasms
71
Ovarian Neoplasms
65
Carcinoma, Hepatocellular
54
Colonic Neoplasms
50
Rectal Neoplasms
49
Neoplasm Metastasis
48
Anxiety Disorders
46
Precursor Cell Lymphoblastic Leukemia-Lymphoma
44
Glioblastoma
44
Hematologic Neoplasms
41
Depression
41
Glioma
37
Disease
37
Melanoma
36
Sarcoma
35
Multiple Myeloma
35
Stomach Neoplasms
34
Carcinoma, Renal Cell
32
Pain
31
Urinary Bladder Neoplasms
30
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Coronary Artery Disease
×
90 days
×
Clear all
NCT04726319
2026-05-06
FHAMe
University of Toronto
Phase NA
Completed
627 enrolled